• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Magle Chemoswed

1.18 SEK

-31.40 %

Less than 1K followers

MAGLE

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-31.40 %
-72.04 %
-84.47 %
-93.30 %
-93.30 %
-95.53 %
-96.50 %
-96.80 %
-94.13 %

Magle Chemoswed is founded on strategic acquisitions aimed at driving growth and diversifying risk. The Group includes three operational areas. Magle Chemoswed, a contract development and manufacturing organization (CDMO). Magle PharmaCept, an established sales and marketing company for the development and direct sales of the Groups medical technology products, and Magle Biopolymers A/S, a specialized manufacturing organization of Dextran technology.

Read more
Market cap
35.71M SEK
Turnover
297.75K SEK
Revenue
282.92M
EBIT %
-44.88 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
5/8
2026

Interim report Q2'26

2/11
2026

Interim report Q3'26

24/2
2027

Annual report '26

Regulatory press release6/7/2026, 5:08 PM

Magle Chemoswed Holding AB – Update on Financing Arrangements and Ongoing Stakeholder Discussions

Magle Chemoswed
Regulatory press release6/7/2026, 1:25 PM

Magle Group Announces Change in Publication Date for Annual Report 2025

Magle Chemoswed
Press release6/3/2026, 1:13 PM

Redeye: Magle Group (Q1 Review): Restructured operations, focus on turnaround

Magle Chemoswed

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release6/2/2026, 12:28 PM

Magle Chemoswed Holding AB (publ) initiates a written procedure to amend the terms and conditions of its senior secured bonds 2025/2028

Magle Chemoswed
Regulatory press release5/31/2026, 10:00 AM

Magle Chemoswed Holding Reports Financial Results For First Quarter 2026

Magle Chemoswed
Regulatory press release5/28/2026, 6:32 AM

Kallelse till årsstämma i Magle Chemoswed Holding AB (publ)

Magle Chemoswed
Regulatory press release5/28/2026, 6:32 AM

Notice to the Annual General Meeting in Magle Chemoswed Holding AB (publ)

Magle Chemoswed
Regulatory press release5/27/2026, 5:26 PM

Magle Group enters into a loan facility agreement of up to SEK 60 million

Magle Chemoswed
Regulatory press release5/26/2026, 2:28 PM

Kommuniké från extra bolagsstämma i Magle Chemoswed Holding AB (publ)

Magle Chemoswed
Regulatory press release5/26/2026, 2:28 PM

Bulletin from the extraordinary general meeting in Magle Chemoswed Holding AB (publ)

Magle Chemoswed
Regulatory press release5/25/2026, 1:00 PM

Calendar Update of the Annual General Meeting 2026

Magle Chemoswed
Regulatory press release5/11/2026, 8:01 PM

MAGLE GROUP HAS RESOLVED ON A SET-OFF ISSUE TO BONDHOLDERS

Magle Chemoswed
Regulatory press release5/8/2026, 7:30 AM

Kallelse till extra bolagsstämma i Magle Chemoswed Holding AB (publ)

Magle Chemoswed
Regulatory press release5/8/2026, 7:30 AM

Notice to extraordinary general meeting in Magle Chemoswed Holding AB (publ)

Magle Chemoswed
Regulatory press release5/5/2026, 6:31 PM

Magle Group announces resignation of board member

Magle Chemoswed
Regulatory press release5/1/2026, 3:26 PM

Magle Group announces resignation of board members

Magle Chemoswed
Regulatory press release4/30/2026, 4:04 PM

Magle Group Announces Outcome of Rights Issue

Magle Chemoswed
Regulatory press release4/28/2026, 5:30 AM

Magle Group Announces Change in Publication Date for Annual Report 2025

Magle Chemoswed
Regulatory press release4/23/2026, 6:51 PM

Magle Chemoswed Holding AB (publ) announces successful completion of the written procedure in relation to its senior secured bonds 2025/2028

Magle Chemoswed
Regulatory press release4/14/2026, 7:28 AM

Magle Group Publishes Information Document in Connection with Upcoming Rights Issue

Magle Chemoswed